Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 17-02-2016 | Practice Area: | Equity Capital Markets |
| Deal Title: | Shield Therapeutics plc AIM Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Travers Smith advised Liberum Capital Limited (as nominated adviser and sole bookrunner) to Shield Therapeutics plc, on its GBP162 million IPO. The IPO involved the conditional placing and subscription of GBP32.5 million of new ordinary shares and the issue of warrants to subscribe for ordinary shares, which, if exercised in full, would generate an additional GBP17.5 million of gross proceeds for Shield Therapeutics.
|
||
| Financial Center: | London | Value: | 0.00-100.00 |
| Advised Party: | Lead Managers | Law Firm | Travers Smith |
| Issuer Jurisdiction- | United Kingdom | Listing Jurisdiction- | United Kingdom |
| Classification: |
Initial Public Offerings LSE: AIM |
Lawyer | Richard Spedding |
